HF 2022: SCD Risk Protection for Newly Diagnosed HF Patients | Dr José González-Costello

Подробнее о видео

Watch on Radcliffe Cardiology:

In this short interview, Dr José González-Costello (University Hospital of Bellvitge, Barcelona, ES) talks about SCD risk protection for newly diagnosed HF patients.

Questions
1. How important is SCD risk protection nowadays?
2. What long term treatment do these patients need?
3. What do you recommend to protect patients in the early phase?

Recorded at Heart Failure 2022, Madrid.
Videographers: Tom Green and Dan Brent

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.